HIV-1 Qualitative Nucleic Acid Test (RNA) by Probe-Based Detection
This test checks for the presence of HIV-1 genetic material (RNA) in your blood, helping doctors monitor disease progression or response to treatment.
["Detects HIV-1 RNA to guide treatment decisions and disease management."]
Key facts at a glance
- LOINC
- 78007-2
- Short code
- HIV 1 pro DNA Bld MC NAA+probe-EntLogNum
- Synonyms
- HIV 1 pro DNA Bld MC NAA+probe-EntLogNum
- Category
- chemistry
- Sample
- whole-blood
- Container
- Lavender-top (EDTA)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- probe-amp-tar
- CPT
- 86701
- Specimen volume
- 3 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 4–24 hours
- Order
- routine
What This Test Measures
The test looks for the genetic material (RNA) of HIV-1, which is produced by the virus when it’s active in your body. If HIV RNA is detected, it suggests the virus is present and replicating, which can help determine if treatment is needed or if it’s working.
Why It’s Done
Healthcare providers may order this test during initial HIV diagnosis, to evaluate disease progression, or to monitor treatment effectiveness in people living with HIV.
Sample Collection and Preparation
A blood sample is taken from a vein, typically in a clinic or lab. The sample is processed to extract viral RNA, which is then analyzed using a specialized probe-based method to detect HIV-1 genetic material.
Test Method and Limitations
This test uses a probe-based nucleic acid amplification technique (qualitative) to identify HIV-1 RNA. While highly sensitive, it cannot distinguish between active and latent virus, and results may not be available immediately due to the need for lab processing.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
A positive result indicates the presence of active HIV-1 replication, which may prompt treatment initiation or adjustments. A negative result suggests no detectable viral RNA at the time of testing, but ongoing monitoring is still essential. This test is critical for guiding antiretroviral therapy (ART) decisions and assessing viral load trends over time.
Short name
HIV RNA Test (Qualitative)
Frequently asked questions
How long does it take to get results?
Can this test be used for early HIV detection?
What if my test is positive?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy